查找临床试验
已按「原发性胆汁性胆管炎」检索，对应国际通用词 primary biliary cholangitis
共找到 45 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:19，每 5 分钟自动同步正在招募不适用NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
United States
年龄 不限 – 不限
Sanford Health
正在招募不适用NCT05335603
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Denmark
年龄 18 Years – 不限
University of Copenhagen
正在招募II 期NCT06286709
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
United Kingdom
年龄 18 Years – 不限
University of Birmingham
正在招募不适用NCT07598669
Austrian PBC Registry
Austria
年龄 18 Years – 不限
Medical University of Vienna
正在招募不适用NCT07205874
Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)
Spain
年龄 18 Years – 80 Years
Hospital Universitario La Paz
正在招募不适用NCT03175471
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
United States
年龄 6 Years – 23 Years
Children's Hospital Medical Center, Cincinnati
正在招募I 期NCT02137668
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
United States
年龄 2 Weeks – 40 Years
Sacramento Pediatric Gastroenterology
正在招募不适用NCT07161245
RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
Spain
年龄 18 Years – 80 Years
Hospital Clinic of Barcelona
正在招募II 期NCT05876182
Vancomycin in Primary Sclerosing Cholangitis in Italy
Italy
年龄 15 Years – 70 Years
University of Milano Bicocca
正在招募I 期NCT06825559
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
United States
年龄 18 Years – 80 Years
Zydus Therapeutics Inc.
正在招募II 期NCT06905054
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
United States
年龄 18 Years – 75 Years
Mayo Clinic
正在招募不适用NCT03146936
Swiss Primary Sclerosing Cholangitis Cohort Study
Switzerland
年龄 不限 – 不限
Fondazione Epatocentro Ticino